These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Long-term effects of radioiodine treatment on thyroid functions and ultrasonographic features in patients with toxic adenoma and toxic multinodular goitre. Koç I; Bahçecioğlu AB; Avcı Merdin F; Araz M; Erdoğan MF Ann Nucl Med; 2023 Jun; 37(6):371-379. PubMed ID: 37010726 [TBL] [Abstract][Full Text] [Related]
4. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism. Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745 [TBL] [Abstract][Full Text] [Related]
5. Long-term Effects of Radioiodine in Toxic Multinodular Goiter: Thyroid Volume, Function, and Autoimmunity. Roque C; Santos FS; Pilli T; Dalmazio G; Castagna MG; Pacini F J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32320467 [TBL] [Abstract][Full Text] [Related]
6. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results]. Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510 [TBL] [Abstract][Full Text] [Related]
7. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres. Silva MN; Rubió IG; Romão R; Gebrin EM; Buchpiguel C; Tomimori E; Camargo R; Cardia MS; Medeiros-Neto G Clin Endocrinol (Oxf); 2004 Mar; 60(3):300-8. PubMed ID: 15008994 [TBL] [Abstract][Full Text] [Related]
9. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome. Walter MA; Christ-Crain M; Eckard B; Schindler C; Nitzsche EU; Müller-Brand J; Müller B Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334 [TBL] [Abstract][Full Text] [Related]
10. Predictors of euthyreosis in hyperthyroid patients treated with radioiodine Stachura A; Gryn T; Kałuża B; Budlewski T; Franek E BMC Endocr Disord; 2020 Jun; 20(1):77. PubMed ID: 32487052 [TBL] [Abstract][Full Text] [Related]
11. Radioiodine treatment of multinodular non-toxic goitre. Nygaard B; Hegedüs L; Gervil M; Hjalgrim H; Søe-Jensen P; Hansen JM BMJ; 1993 Oct; 307(6908):828-32. PubMed ID: 8401123 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of radioiodine (131-I) as definitive therapy in patients with autoimmune and non-autoimmune hyperthyroidism. Tarantini B; Ciuoli C; Di Cairano G; Guarino E; Mazzucato P; Montanaro A; Burroni L; Vattimo AG; Pacini F J Endocrinol Invest; 2006; 29(7):594-8. PubMed ID: 16957406 [TBL] [Abstract][Full Text] [Related]
13. Five-year follow-up of percutaneous ethanol injection for the treatment of hyperfunctioning thyroid nodules: a study of 117 patients. Monzani F; Caraccio N; Goletti O; Lippolis PV; Casolaro A; Del Guerra P; Cavina E; Miccoli P Clin Endocrinol (Oxf); 1997 Jan; 46(1):9-15. PubMed ID: 9059552 [TBL] [Abstract][Full Text] [Related]
14. Radioiodine and percutaneous ethanol injection in the treatment of large toxic thyroid nodule: a long-term study. Zingrillo M; Torlontano M; Ghiggi MR; Frusciante V; Varraso A; Liuzzi A; Trischitta V Thyroid; 2000 Nov; 10(11):985-9. PubMed ID: 11128727 [TBL] [Abstract][Full Text] [Related]
15. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy. Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679 [TBL] [Abstract][Full Text] [Related]
16. Radiometabolic treatment of hyperthyroidism with a calculated dose of 131-iodine: results of one-year follow-up. Regalbuto C; Marturano I; Condorelli A; Latina A; Pezzino V J Endocrinol Invest; 2009 Feb; 32(2):134-8. PubMed ID: 19411811 [TBL] [Abstract][Full Text] [Related]
17. The occurrence of hypothyroidism following radioactive iodine treatment of toxic nodular goiter is related to the TSH level. Adamali HI; Gibney J; O'Shea D; Casey M; McKenna TJ Ir J Med Sci; 2007 Sep; 176(3):199-203. PubMed ID: 17632747 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose]. Bakker SC; Zanin DE; Zweers EJ Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370 [TBL] [Abstract][Full Text] [Related]
19. The Presence of Anti-TPO Antibodies Increase the Likelihood of Post-I131 Hypothyroidism. Quataert F; Bravenboer B; Keyaerts M; Andreescu CE Horm Metab Res; 2024 Feb; 56(2):134-141. PubMed ID: 37931916 [TBL] [Abstract][Full Text] [Related]
20. Effects of radioiodine therapy in hyperthyroidism (thyroid function, thyroid volume, Graves' ophtalmopathy, thyrotoxic heart disease). Ursu HI; Dumitriu L; Grigorie D; Simescu M; Vaida E; Belgun M; Popovici D Rom J Endocrinol; 1993; 31(3-4):155-63. PubMed ID: 7697064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]